Pauling David Insider Trades

Insider Trading History

Track insider trading activity for Pauling David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $0 0 shares
Last Trade
Mar 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.4k 675 shares
$21.31
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $272k 10,025 shares
Last Trade
Mar 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.4k 675 shares
$21.31
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $265k 9,748 shares
Last Trade
Mar 04, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.9k 277 shares
$21.31
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $254k 9,350 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.9k 970 shares
$20.55
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $913k 33,600 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$777k 37,800 shares
$20.54
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $192k 7,069 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.4k 2,356 shares
$20.54
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $280k 10,320 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.4k 2,356 shares
$20.54
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $216k 7,964 shares
Last Trade
Mar 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.3k 551 shares
$20.47
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $231k 8,515 shares
Last Trade
Mar 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.5k 1,342 shares
$20.47
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $45.8k 1,686 shares
Last Trade
Mar 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.5k 1,342 shares
$20.47
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $196k 7,200 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.7k 7,200 shares
$10.38
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $1.95M 71,737 shares
Last Trade
Oct 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10k 12,504 shares
$0.80
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $2.76M 101,500 shares
Last Trade
Apr 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$55.8k 101,500 shares
$0.55
$27.18
Sutro Biopharma
Sutro Biopharma STRO
Chief Admin. Ofcr. & GC
Holding Value $2.68M 98,758 shares
Last Trade
Apr 04, 2025 Sale
$97.3k 179,450 shares
$0.54
$27.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up